(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHYDUXON

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHYDUXON

ST13

US500000090154042

Class

5

Filing

90154042

Registration

6533997

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

02/14/2024

Trademark type

Word

Nice classes

5

Filing date

09/02/2020

Registration date

10/26/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/26/2021

Last transaction

02/14/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

New Taipei City, TW

Examiner

CASE, LEIGH CAROLINE

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

FULLHOPE BIOMEDICAL CO., LTD.

Representatives

Robert J. Kenney Willcox & Savage, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Vaccine for human use; Immunostimulants; Pre-filled syringes for the treatment of cancer; Anticancer drug; Medicines for the treatment of cancer; Medicinal agent for the treatment of cancer; Biological preparations for the treatment of cancer; Blood for medical purposes; Vaccines; Adjuvants for medical purposes; Albuminous preparations for medical purposes; Pharmaceutical drugs for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Diagnostic preparations for medical purposes; Diagnostic biomarker reagents for medical purposes; Cells for medical purposes; Immunomodulatory Pharmaceutical preparationsImmune cells for the treatment of cancer; Pharmaceuticals for testing the human immune system; Reagents for medical use; Culture media for cultivating cells

Publications

History of USPTO decisions and trademark events.

23 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/13/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

02/13/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/13/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/13/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/26/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/10/2021

PUBO

PUBLISHED FOR OPPOSITION

08/10/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/21/2021

OTHE

CASE RETURNED TO EXAMINATION

06/28/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

06/28/2021

PCGR

PETITION TO DIRECTOR GRANTED

06/26/2021

APET

ASSIGNED TO PETITION STAFF

06/25/2021

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

05/28/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

04/13/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/16/2021

PUBO

PUBLISHED FOR OPPOSITION

02/16/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/27/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2021

DOCK

ASSIGNED TO EXAMINER

01/07/2021

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

10/30/2020

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

10/30/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/08/2020

NWAP

NEW APPLICATION ENTERED

09/05/2020

Continuous trademark protection

Get notified about every new filing that threatens PHYDUXON or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.